Show simple item record

dc.contributor.authorTonner, E
dc.contributor.authorCrawshaw, S
dc.contributor.authorDolman, M
dc.contributor.authorChambers, E
dc.contributor.authorWilliamson, J
dc.contributor.authorThomas, N
dc.contributor.authorHobbs, R
dc.contributor.authorLittle, P
dc.contributor.authorButler, C
dc.contributor.authorEvans, P
dc.date.accessioned2023-07-25T09:57:03Z
dc.date.issued2023-07-01
dc.date.updated2023-07-25T08:21:01Z
dc.description.abstractBackground In the summer of 2021, after 18 months of the COVID-19 pandemic, there were still no clear evidence-based interventions for COVID-19 infection in the community. Recruiting large numbers at pace was a challenge to urgently generate the evidence needed to inform care within the pandemic. Aim To develop efficient, user-friendly recruitment methods to offer large numbers of acutely unwell, infectious people with COVID-19 UK the opportunity to participate in a priority trial and test the clinical and cost-effectiveness of molnupiravir. Method PANORAMIC was an adaptive platform clinical trial with participants randomised to either a novel antiviral or usual care. Participants needed to start antiviral medication within 5 days of symptom onset. Innovative methods of identifying positive individuals within general practice were developed, as well as online research procedures for delivery and follow-up, including through www.panoramictrial.org. Results Novel methods of recruitment were developed in collaboration between the study team and the NIHR Clinical Research Network (CRN), and continually adapted during the study. These included virtual recruitment through the study website combined with GP recruitment via hub and spoke models: this was supported by data, stakeholder, and workforce infrastructure across devolved administration. PANORAMIC was the fastest recruiting study ever delivered by primary care in the NIHR CRN. There were 26 411 participants recruited. Final molnupiravir results will also be presented. Conclusion Large-scale, at-pace recruitment supported by the English CRN and equivalent networks across the UK, is achievable in a pandemic situation, producing potentially game-changing results of national and international importance.en_GB
dc.format.extentbjgp23x733665-
dc.format.mediumPrint
dc.identifier.citationVol. 73 (suppl 1), article bjgp23x733665en_GB
dc.identifier.doihttps://doi.org/10.3399/bjgp23X733665
dc.identifier.urihttp://hdl.handle.net/10871/133652
dc.identifierORCID: 0000-0002-5277-3545 (Evans, Philip)
dc.identifierScopusID: 55732332800 | 7402236028 (Evans, Philip)
dc.language.isoenen_GB
dc.publisherRoyal College of General Practitionersen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/37479296en_GB
dc.rights.embargoreasonUnder indefinite embargo due to publisher policy  en_GB
dc.rights© British Journal of General Practice 2023en_GB
dc.titleInnovative methods of recruitment through the NIHR Clinical Research Network (CRN) into large-scale pandemic trials in primary care: the PANORAMIC trial experienceen_GB
dc.typeArticleen_GB
dc.date.available2023-07-25T09:57:03Z
dc.identifier.issn0960-1643
exeter.place-of-publicationEngland
dc.descriptionThis is the final version. Available from the Royal College of General Practitioners via the DOI in this recorden_GB
dc.identifier.eissn1478-5242
dc.identifier.journalBritish Journal of General Practiceen_GB
dc.relation.ispartofBr J Gen Pract, 73(suppl 1)
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2023
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2023-07-01
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2023-07-25T09:53:10Z
refterms.versionFCDVoR
refterms.panelAen_GB
refterms.dateFirstOnline2023-07-01


Files in this item

This item appears in the following Collection(s)

Show simple item record